BR9911344A - Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. - Google Patents
Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.Info
- Publication number
- BR9911344A BR9911344A BR9911344-9A BR9911344A BR9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A BR 9911344 A BR9911344 A BR 9911344A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- kit
- pharmaceutical formulation
- male contraception
- ment undecanoate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 abstract 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- JFEPJTGMGDGPHJ-PNKHAZJDSA-N (8r,9s,10r,13s,14s)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 JFEPJTGMGDGPHJ-PNKHAZJDSA-N 0.000 abstract 1
- -1 1 -oxoundecyl Chemical group 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
- 150000003515 testosterones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSTO, UNDECANOATO DE MENT, USO DO MESMO, FORMULAçãO FARMACêUTICA, E, KIT PARA A CONTRACEPçãO MASCULINA" A invenção refere-se ao novo andrógeno (7<244>, 7 <225>) -7-metil-17[(1-oxoundecil)oxi]estr-4-en-3-ona ( undecanoato de MENT). Este composto se distingue favoravelmente de outros derivados de testosterona pelo fato de que ele possui uma boa solubilidade em meios oleosos. Ele exibe particularmente uma boa potência dissolvida em relação à testosterona. O composto é particularmente adequado para a administração por meio de injeção.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202052 | 1998-06-19 | ||
| PCT/EP1999/004102 WO1999067271A1 (en) | 1998-06-19 | 1999-06-14 | Testosterone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9911344A true BR9911344A (pt) | 2001-03-13 |
Family
ID=8233831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9911344-9A BR9911344A (pt) | 1998-06-19 | 1999-06-14 | Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6437158B1 (pt) |
| EP (1) | EP1087986B1 (pt) |
| JP (1) | JP2002518514A (pt) |
| KR (1) | KR100596649B1 (pt) |
| CN (1) | CN1172949C (pt) |
| AT (1) | ATE215961T1 (pt) |
| AU (1) | AU756739B2 (pt) |
| BR (1) | BR9911344A (pt) |
| CA (1) | CA2333985C (pt) |
| CZ (1) | CZ293319B6 (pt) |
| DE (1) | DE69901250T2 (pt) |
| DK (1) | DK1087986T3 (pt) |
| ES (1) | ES2175989T3 (pt) |
| HU (1) | HUP0102274A3 (pt) |
| ID (1) | ID27260A (pt) |
| IL (1) | IL139689A (pt) |
| NO (1) | NO316518B1 (pt) |
| NZ (1) | NZ508299A (pt) |
| PL (1) | PL191285B1 (pt) |
| PT (1) | PT1087986E (pt) |
| RU (1) | RU2216546C2 (pt) |
| SK (1) | SK282796B6 (pt) |
| TR (1) | TR200003743T2 (pt) |
| WO (1) | WO1999067271A1 (pt) |
| ZA (1) | ZA200006813B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756366B1 (en) * | 1999-04-06 | 2004-06-29 | Akzo Nobel N.V. | Orally active androgens |
| PL366235A1 (en) * | 2000-07-28 | 2005-01-24 | Akzo Nobel N.V. | 16alpha-methyl or ethyl substituted estrogens |
| JP3774888B2 (ja) * | 2001-11-28 | 2006-05-17 | 日本化薬株式会社 | ステロイド類化合物のｌｃ−ｍｓによる高感度検出法 |
| TW200400041A (en) * | 2002-05-30 | 2004-01-01 | Akzo Nobel Nv | Use of new etonogestrel esters |
| TW200403065A (en) | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
| TW200404552A (en) * | 2002-05-30 | 2004-04-01 | Akzo Nobel Nv | Self administered contraception |
| GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| JO2505B1 (en) * | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
| JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
| PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
| EP1879382B1 (en) | 2006-07-10 | 2017-09-06 | Samsung Electronics Co., Ltd. | Multi-screen display apparatus and method for digital broadcast receiver |
| WO2008101030A1 (en) * | 2007-02-13 | 2008-08-21 | The Regents Of The University Of California | Methods for amplifying steroid hormone effects |
| US20090018107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase muscle strength |
| US20090017107A1 (en) * | 2007-07-13 | 2009-01-15 | Oral Delivery Technology Ltd. | Novel composition to increase libido |
| US20100303937A1 (en) * | 2009-06-01 | 2010-12-02 | Michael Farber | Novel composition to increase testosterone levels |
| CN102558267A (zh) * | 2012-01-13 | 2012-07-11 | 宜城市共同药业有限公司 | 庚酸睾酮的制备方法 |
| CN104487114A (zh) * | 2012-04-06 | 2015-04-01 | 安塔雷斯药品公司 | 针头辅助喷射注射给予睾酮组合物 |
| PT2953667T (pt) | 2013-02-11 | 2020-01-28 | Antares Pharma Inc | Dispositivo de injeção a jato auxiliado por agulha tendo força de gatilho reduzida |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5342834A (en) * | 1989-04-07 | 1994-08-30 | The Population Council, Inc. | Method for androgen supplementation |
-
1999
- 1999-06-14 CN CNB998075175A patent/CN1172949C/zh not_active Expired - Fee Related
- 1999-06-14 WO PCT/EP1999/004102 patent/WO1999067271A1/en active IP Right Grant
- 1999-06-14 DE DE69901250T patent/DE69901250T2/de not_active Expired - Fee Related
- 1999-06-14 SK SK1940-2000A patent/SK282796B6/sk not_active IP Right Cessation
- 1999-06-14 EP EP99929208A patent/EP1087986B1/en not_active Expired - Lifetime
- 1999-06-14 JP JP2000555922A patent/JP2002518514A/ja active Pending
- 1999-06-14 ID IDW20002632A patent/ID27260A/id unknown
- 1999-06-14 TR TR2000/03743T patent/TR200003743T2/xx unknown
- 1999-06-14 AT AT99929208T patent/ATE215961T1/de not_active IP Right Cessation
- 1999-06-14 KR KR1020007014182A patent/KR100596649B1/ko not_active Expired - Fee Related
- 1999-06-14 HU HU0102274A patent/HUP0102274A3/hu unknown
- 1999-06-14 IL IL13968999A patent/IL139689A/en not_active IP Right Cessation
- 1999-06-14 PT PT99929208T patent/PT1087986E/pt unknown
- 1999-06-14 NZ NZ508299A patent/NZ508299A/xx unknown
- 1999-06-14 US US09/719,927 patent/US6437158B1/en not_active Expired - Fee Related
- 1999-06-14 AU AU46101/99A patent/AU756739B2/en not_active Ceased
- 1999-06-14 DK DK99929208T patent/DK1087986T3/da active
- 1999-06-14 BR BR9911344-9A patent/BR9911344A/pt not_active Application Discontinuation
- 1999-06-14 CA CA002333985A patent/CA2333985C/en not_active Expired - Fee Related
- 1999-06-14 PL PL344987A patent/PL191285B1/pl not_active IP Right Cessation
- 1999-06-14 CZ CZ20004779A patent/CZ293319B6/cs not_active IP Right Cessation
- 1999-06-14 ES ES99929208T patent/ES2175989T3/es not_active Expired - Lifetime
- 1999-06-14 RU RU2001101892/04A patent/RU2216546C2/ru not_active IP Right Cessation
-
2000
- 2000-11-21 ZA ZA200006813A patent/ZA200006813B/en unknown
- 2000-12-18 NO NO20006455A patent/NO316518B1/no unknown
-
2002
- 2002-06-21 US US10/177,989 patent/US20040033999A1/en not_active Abandoned
-
2004
- 2004-10-13 US US10/964,076 patent/US6989378B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9911344A (pt) | Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. | |
| ES2114931T3 (es) | Nuevos esteres esteroidales. | |
| BR0107445A (pt) | Formulação farmacêutica, uso de fulvestrante na preparação de uma formulação farmacêutica, e, seringa ou frasco | |
| EP2348032A3 (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent | |
| ITMI921601A1 (it) | Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci. | |
| CY1108093T1 (el) | Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη | |
| KR920701200A (ko) | 신규의 4h-3,1-벤조옥사진-4-온 유도체 | |
| AU3559193A (en) | New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them | |
| ES2192031T3 (es) | Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| ES514267A0 (es) | "un procedimiento para la preparacion de derivados de pirrolidina". | |
| NO800447L (no) | Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser | |
| AU1178588A (en) | New 19-norsteroids substituted at the 7-position, their preparation, their application as drugs and the pharmaceutical compositions containing them | |
| KR960007592A (ko) | 신규한 피롤로카바졸 | |
| DE59208058D1 (de) | Neue Tetrazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| MY128392A (en) | 6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT | |
| DK1051177T3 (da) | Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase | |
| AR029509A1 (es) | Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales | |
| NZ505614A (en) | Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets | |
| NO943187D0 (no) | Indolderivater som steroid 5-alfa-reduktasehemmere | |
| BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
| PA8495001A1 (es) | Nuevas formas cristalinas de un antibiotico macrolido. | |
| PA8475701A1 (es) | Derivados de 3(2-oxo-[1,3']bipirrolidinil-3-ilidenmetil)-cephems | |
| AR018888A1 (es) | Un derivado de testosterona, uso del mismo, una formulacion farmaceutica que comprende a dicho derivado y un kit para la anticoncepcion masculina | |
| KR940018351A (ko) | 노나테트라에노산 유도체 | |
| ES2054827T3 (es) | Uso de alquil fosfatos para la estabilizacion de composiciones tixotropicas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |